Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
 
 
Email
mdccwj@nus.edu.sg
 
 

Publications

Refined By:
Subject:  Hematology
Type:  Article

Results 1-20 of 20 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
120-Sep-2018Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisTeoh, Phaik Ju ; An, Omer ; Chung, Tae-Hoon ; Chooi, Jing Yuan ; Toh, Sabrina HM ; Fan, Shuangyi ; Wang, Wilson ; Koh, Bryan TH; Fullwood, Melissa J ; Ooi, Melissa G ; de Mel, Sanjay; Soekojo, Cinnie Y; Chen, Leilei ; Ng, Siok Bian ; Yang, Henry ; Chng, Wee Joo 
21-Jun-2017Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVORChng, W-J ; Goldschmidt, H; Dimopoulos, MA; Moreau, P; Joshua, D; Palumbo, A; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Feng, S; Aggarwal, S; Hajek, R
31-Aug-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaMadan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
41-Dec-2016Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (vol 30, pg 1672, 2016)Madan, V ; Shyamsunder, P ; Han, L; Mayakonda, A ; Nagata, Y; Sundaresan, J ; Kanojia, D ; Yoshida, K; Ganesan, S; Hattori, N; Fulton, N; Tan, KT ; Alpermann, T; Kuo, MC; Rostami, S; Matthews, J; Sanada, M; Liu, L-Z ; Shiraishi, Y; Miyano, S; Chendamarai, E; Hou, HA; Malnassy, G; Ma, T; Garg, M ; Ding, LW ; Sun, QY ; Chien, W ; Ikezoe, T; Lill, M; Biondi, A; Larson, RA; Powell, BL; Lubbert, M; Chng, WJ ; Tien, HF; Heuser, M; Ganser, A; Koren-Michowitz, M; Kornblau, SM; Kantarjian, HM; Nowak, D; Hofmann, WK; Yang, H ; Stock, W; Ghavamzadeh, A; Alimoghaddam, K; Haferlach, T; Ogawa, S; Shih, LY; Mathews, V; Koeffler, HP 
523-Apr-2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A; Rajkumar, S Vincent; Weisel, Katja C; Moreau, Philippe; Chng, Wee-Joo ; Mikala, Gabor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Victoria Mateos, Maria
63-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo 
71-Feb-2018Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesNg, Siok-Bian ; Chung, Tae-Hoon; Kato, Seiichi; Nakamura, Shigeo; Takahashi, Emiko; Ko, Young-Hyeh; Khoury, Joseph D; Yin, C Cameron; Soong, Richie; Jeyasekharan, Anand D ; Hoppe, Michal Marek; Selvarajan, Viknesvaran; Tan, Soo-Yong; Lim, Soon-Thye; Ong, Choon-Kiat ; Nairismagi, Maarja-Liisa; Maheshwari, Priyanka ; Choo, Shoa-Nian ; Fan, Shuangyi ; Lee, Chi-Kuen ; Chuang, Shih-Sung; Chng, Wee-Joo 
83-Aug-2015Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotypeNg, Siok-Bian ; Ohshima, Koichi; Selvarajan, Viknesvaran ; Huang, Gaofeng ; Choo, Shoa-Nian ; Miyoshi, Hiroaki; Shimizu, Norio; Reghunathan, Renji ; Chua, Hsin-Chieh ; Yeoh, Allen Eng-Juh ; Thuan-Chong, Quah ; Koh, Liang-Piu ; Tan, Poh-Lin ; Chng, Wee-Joo 
918-Aug-2016EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphomaYan, Junli; Li, Boheng ; Lin, Baohong; Lee, Pei Tsung ; Chung, Tae-Hoon; Tan, Joy; Bi, Chonglei; Lee, Xue Ting ; Selvarajan, Viknesvaran; Ng, Siok-Bian ; Yang, Henry ; Yu, Qiang; Chng, Wee-Joo 
1031-Jan-2022Genomic characterization of functional high-risk multiple myeloma patientsSoekojo, Cinnie Yentia; Chung, Tae-Hoon ; Furqan, Muhammad Shaheryar; Chng, Wee Joo 
1112-Aug-2021High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaOng, Shin Yeu ; de Mel, Sanjay; Grigoropoulos, Nicholas Francis ; Chen, Yunxin ; Tan, Yan Chin; Tan, Melinda Si Yun ; Ng, Lawrence Cheng Kiat ; Lee, Yuh Shan; Phipps, Colin; Goh, Yeow Tee ; Yong, Kar Ying; Liu, Xin; Chng, Wee Joo ; Lim, Soon Thye ; Nagarajan, Chandramouli 
121-May-2020IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplificationTeoh, Phaik Ju ; Chung, Tae-Hoon; Chng, Pamela YZ; Toh, Sabrina HM ; Chng, Wee Joo 
131-Jan-2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyMoreau, P; Joshua, D; Chng, W-J ; Palumbo, A; Goldschmidt, H; Hajek, R; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Aggarwal, S; Feng, S; Dimopoulos, MA
141-Feb-2021Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportMurray, David L; Puig, Noemi; Kristinsson, Sigurdur; Usmani, Saad Z; Dispenzieri, Angela; Bianchi, Giada; Kumar, Shaji; Chng, Wee Joo ; Hajek, Roman; Paiva, Bruno; Waage, Anders; Rajkumar, S Vincent; Durie, Brian
155-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
1612-Feb-2021Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaJia, Yunlu; Zhou, Jianbiao; Tan, Tze King ; Chung, Tae-Hoon; Wong, Regina Wan Ju ; Chooi, Jing-Yuan ; Lim, Julia Sze Lynn ; Sanda, Takaomi ; Ooi, Melissa; De Mel, Sanjay; Soekojo, Cinnie; Chen, Yongxia; Zhang, Enfan; Cai, Zhen; Shen, Peng; Ruan, Jian; Chng, Wee-Joo 
1713-Sep-2018Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphomaSong, Tammy Linlin; Nairismagi, Maarja-Liisa; Laurensia, Yurike; Lim, Jing-Quan ; Tan, Jing; Li, Zhi-Mei; Pang, Wan-Lu; Kizhakeyil, Atish; Wijaya, Giovani-Claresta; Huang, Da-Chuan; Nagarajan, Sanjanaa; Chia, Burton Kuan-Hui; Cheah, Daryl; Liu, Yan-Hui; Zhang, Fen; Rao, Hui-Lan; Tang, Tiffany; Wong, Esther Kam-Yin; Bei, Jin-Xin; Iqbal, Jabed; Grigoropoulos, Nicholas-Francis; Ng, Siok-Bian ; Chng, Wee-Joo ; Teh, Bin-Tean ; Tan, Soo-Yong; Verma, Navin Kumar; Fan, Hao ; Lim, Soon-Thye; Ong, Choon-Kiat 
188-Oct-2019Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma NetworkSoekojo, Cinnie Yentia; Kim, Kihyun; Huang, Shang-Yi; Chim, Chor-Sang; Takezako, Naoki; Asaoku, Hideki; Kimura, Hideo; Kosugi, Hiroshi; Sakamoto, Junichi; Gopalakrishnan, Sathish Kumar; Nagarajan, Chandramouli; Wei, Yuan; Moorakonda, Rajesh; Lee, Shu Ling; Lee, Je Jung; Yoon, Sung-Soo; Kim, Jin Seok; Min, Chang Ki; Lee, Jae-Hoon; Durie, Brian; Chng, Wee Joo 
1926-Aug-2021Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trialsChen, Yan-Ting; Valent, Erik T; van Beers, Erik H; Kuiper, Rowan; Oliva, Stefania; Haferlach, Torsten; Chng, Wee-Joo ; van Vliet, Martin H; Sonneveld, Pieter; Larocca, Alessandra
201-Oct-2017RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCSelvarajan, V ; Osato, M ; Nah, GSS ; Yan, J ; Chung, T-H ; Voon, DC-C ; Ito, Y ; Ham, MF; Salto-Tellez, M ; Shimizu, N; Choo, S-N; Fan, S; Chng, W-J ; Ng, S-B